Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report

Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival <10% and no standard therapy. We report the first case to our knowledge of metastatic EMPD with treatment response to checkpoint inhibitor immunotherapy. The patient had diffusely metas...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Case Rep Oncol
Main Authors: Guercio, Brendan John, Iyer, Gopa, Kidwai, Wajih Zaheer, Lacouture, Mario E., Ghafoor, Soleen, Rossi, Anthony M., Assis, David N., Chen, Ying-Bei, Busam, Klaus J., Janjigian, Yelena Y., Jhaveri, Komal, Feldman, Darren R., Capozzi, Anne, Figueroa, Vanessa, Bajorin, Dean F., Rosenberg, Jonathan E., Hollmann, Travis J., Funt, Samuel A.
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2021
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983595/
https://ncbi.nlm.nih.gov/pubmed/33790764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000514345
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares